OncoSil Medical (ASX:OSL) 3-Year EBITDA Growth Rate : 17.80% (As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical 3-Year EBITDA Growth Rate?

OncoSil Medical's EBITDA per Share for the six months ended in Jun. 2024 was A$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 17.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of OncoSil Medical was 52.40% per year. The lowest was -233.20% per year. And the median was -5.30% per year.

Competitive Comparison of OncoSil Medical's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, OncoSil Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSil Medical's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OncoSil Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where OncoSil Medical's 3-Year EBITDA Growth Rate falls into.

OncoSil Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

OncoSil Medical (ASX:OSL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

OncoSil Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSil Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.oncosil.com

OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines